Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Oct 22, 2026
TickeronGET DAILY SIGNALS
DOW vs LYB: Divergent Paths Amid Petrochemical Supply Shifts

DOW vs LYB: Divergent Paths Amid Petrochemical Supply Shifts

Key Takeaways

  • Both DOW and LYB have benefited from higher petrochemical prices following Middle East supply disruptions, but they are executing very different strategies.
  • DOW delivered a strong third quarter, beating earnings estimates on higher polyethylene prices and aggressive cost-cutting, and guided above expectations for the fourth quarter.
  • LYB posted a large second-quarter earnings beat and continues reshaping its portfolio, though near-term pricing pressure has led analysts to trim expectations.
  • DOW is leaning into self-help initiatives and workforce reductions, while LYB is divesting assets and streamlining its cost base through a cash improvement program.
  • Both stocks have outperformed the broader market over the past year, making relative performance and market positioning the key differentiators.

Setting the Stage

Dow Inc. and LyondellBasell Industries are two of the largest chemical and materials companies in the world, and their shares often move in tandem with the same forces: petrochemical pricing, energy costs, and global demand for plastics. A stock comparison between DOW and LYB is especially relevant now, because both have been navigating a disrupted global supply environment while pursuing separate restructuring paths. Investors focused on cyclicals, dividends, and materials-sector rotation may find this comparison useful for understanding how these peers differ in growth drivers, balance-sheet positioning, and market sentiment despite operating in closely related businesses. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.

DOW's Recent Results and Self-Help Focus

DOW is a Midland, Michigan–based materials science company that produces packaging and specialty plastics, industrial intermediates, and performance materials and coatings. In its most recent quarter, the company reported net sales of roughly $11.3 billion, up 13% year over year, with adjusted earnings per share of $0.71, ahead of consensus estimates. Operating EBITDA rose to about $1.55 billion from $868 million a year earlier.

Recent performance has been driven by higher polyethylene prices across all regions, which management attributed in part to tighter global supply following Middle East disruptions. The company has also accelerated self-help measures, including a plan to cut roughly 13% of its workforce and the closure of higher-cost European upstream assets. DOW guided fourth-quarter adjusted core earnings above Wall Street estimates, supported by continued pricing strength and cost savings, and its shares have risen sharply on a year-to-date basis, outpacing the S&P 500. From what I see, the cost discipline here stands out as a steadying factor.

LYB's Portfolio Reshaping and Near-Term Pressures

LYB, LyondellBasell Industries N.V., is a global chemical company headquartered in Houston, Texas, with roots in the Netherlands. It manufactures plastics, chemicals, and advanced polymers, and has been exiting lower-margin businesses to sharpen its focus. In its most recent reported quarter, the company posted EPS of $4.30, well above the consensus estimate of about $3.44, with revenue of roughly $9.18 billion, up nearly 20% year over year. That strength reflected higher polyethylene margins and favorable cost positioning for its U.S. Gulf Coast assets.

LYB has completed the sale of four European assets and continues to execute a cash improvement plan targeting $500 million of incremental cash flow. However, analysts have flagged softer third-quarter pricing as increased exports from China pressured polyethylene markets, prompting some firms to trim price targets even while maintaining constructive longer-term views. LYB shares have also delivered strong relative performance over the past year, though near-term sentiment has been more mixed ahead of its next earnings release. I’m watching this closely as the pricing dynamics evolve.

Direct Comparison of Strategies and Momentum

Although DOW and LYB share exposure to petrochemical pricing, their business models differ meaningfully. DOW operates a more integrated, downstream-oriented portfolio spanning packaging, infrastructure, and consumer-facing materials, while LYB is anchored in olefins and polyolefins with a cost-advantaged U.S. Gulf Coast position. Growth drivers also diverge: DOW is emphasizing self-help cost programs and productivity gains, whereas LYB is reshaping its portfolio through divestitures and disciplined capital spending.

On momentum, both stocks have outperformed the broader market over the past year, but the pattern differs. DOW's recent quarter showed broad-based improvement with an upbeat forward guide, while LYB faces near-term pricing headwinds even as its asset base remains structurally advantaged. Risk factors include commodity-price cyclicality, energy costs, and geopolitical supply disruptions for both. Market sentiment appears comparatively firmer around DOW's execution narrative, while analyst views on LYB are split between bullish cost-positioning arguments and concerns about softening pricing.

AI Assessment and Outlook

Based on observable factors, Tickeron's AI would likely lean toward DOW in the current environment. The combination of a broad-based earnings beat, an above-consensus forward outlook, and consistent self-help execution suggests steadier trend consistency and more visible near-term catalysts. LYB's cost-advantaged asset base and portfolio transformation remain credible long-term strengths, but softer third-quarter pricing and mixed analyst revisions introduce more uncertainty into its short-term trajectory. This is a probabilistic assessment grounded in momentum, stability, and relative positioning rather than a definitive forecast, and the balance could shift quickly if petrochemical pricing dynamics change.

Exploring Systematic Approaches in Materials

In my own research process, I often review Tickeron's Trending AI Robots page for a curated look at automated strategies active in sectors like chemicals. It highlights bots with strong recent momentum across different timeframes and styles, complete with performance stats, which helps me cross-check ideas without sifting through every option manually. This keeps the focus on data-driven signals that align with current market conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LYB, DOW

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


LYB's RSI Indicator ascending out of oversold territory

The RSI Oscillator for LYB moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 16 of the 23 cases the stock moved higher. This puts the odds of a move higher at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on LYB as a result. In 62 of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

The Moving Average Convergence Divergence (MACD) for LYB just turned positive on October 08, 2026. Looking at past instances where LYB's MACD turned positive, the stock continued to rise in 30 of 49 cases over the following month. The odds of a continued upward trend are 61%.

LYB moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where LYB advanced for three days, in 183 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for LYB crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

LYB broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LYB entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.915) is normal, around the industry mean (2.360). P/E Ratio (-56.491) is within average values for comparable stocks, (-17.218). Projected Growth (PEG Ratio) (1.526) is also within normal values, averaging (1.548). Dividend Yield (0.044) settles around the average of (0.040) among similar stocks. P/S Ratio (0.670) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. LYB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.45B. The market cap for tickers in the group ranges from 50 to 230.75B. LIN holds the highest valuation in this group at 230.75B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was 0%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -6%. YMAT experienced the highest price growth at 43%, while ODC experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -1%. For the same stocks of the Industry, the average monthly volume growth was 11% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 55
Price Growth Rating: 54
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 35 (-100 ... +100)
View a ticker or compare two or three
LYB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of petrochemicals

Industry ChemicalsSpecialty

Industry
Chemicals Specialty
Address
One Vine Street
Phone
+44 2072202600
Employees
18970
Web
https://www.lyondellbasell.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.